Reports
Reports
Sale
The global healthcare distribution market attained a value of USD 935.46 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 7.1%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is growing due to the increasing prevalence of chronic diseases. The Asia Pacific is emerging as a significant market for the product due to the rising pharmaceutical industry and the enactment of strict regulations in the healthcare sector in regions like India and China.
The various types of healthcare distribution include:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market can be broadly categorised on the basis of its end-use into:
The EMR report looks into the regional healthcare distribution markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The global healthcare distribution market is being driven by the growing significance of generics and the expanding biosimilars and medical equipment industries due to the advancement in technology. The market is further aided by factors such as the rising preference of track and trace solutions, increased dispensing of specialty drugs, and the rising acceptance of biopharmaceuticals. While North America dominates the market, the Asia Pacific is expected to emerge as a significant market for the product during the forecast period, owing to growing regulatory necessities in the healthcare sector, along with the growing pharmaceutical companies in regions such as China and India.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global healthcare distribution market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Healthcare Distribution Market Analysis
8.1 Key Industry Highlights
8.2 Global Healthcare Distribution Historical Market (2018-2023)
8.3 Global Healthcare Distribution Market Forecast (2024-2032)
8.4 Global Healthcare Distribution Market by Type
8.4.1 Pharmaceutical Product Distribution Services
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Over-The-Counter Drugs/Vitamins
8.4.1.3.2 Brand-Name/Innovator Drugs
8.4.1.3.3 Generic Drugs
8.4.2 Medical Device Distribution Services
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Biopharmaceutical Product Distribution Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Type
8.4.3.3.1 Monoclonal Antibodies
8.4.3.3.2 Vaccines
8.4.3.3.3 Recombinant Proteins
8.4.3.3.4 Blood and Blood Products
8.4.3.3.5 Others
8.5 Global Healthcare Distribution Market by End Use
8.5.1 Retail Pharmacies
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Hospital Pharmacies
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Healthcare Distribution Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Healthcare Distribution Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Healthcare Distribution Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Healthcare Distribution Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Healthcare Distribution Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Healthcare Distribution Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 McKesson Corporation
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 AmerisourceBergen Corporation
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Cardinal Health Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Owens and Minor, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Morris and Dickson Co. L.L.C.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Priority Healthcare Distribution, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 FFF Enterprises, Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Attain Med, Inc.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Dakota Drug, Inc.
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Healthcare Distribution Market: Key Industry Highlights, 2018 and 2032
2. Global Healthcare Distribution Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Healthcare Distribution Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Healthcare Distribution Historical Market: Breakup by End Use (USD Million), 2018-2023
5. Global Healthcare Distribution Market Forecast: Breakup by End Use (USD Million), 2024-2032
6. Global Healthcare Distribution Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Healthcare Distribution Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Healthcare Distribution Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Healthcare Distribution Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Healthcare Distribution Market Structure
The global healthcare distribution market attained a value of nearly USD 935.46 billion in 2023.
The market is projected to grow at a CAGR of 7.1% between 2024 and 2032.
The major drivers of the industry include growing significance of generics and the expanding biosimilars and medical equipment industries due to the advancement in technology.
The increasing prevalence of chronic diseases is expected to be a key trend guiding the growth of the industry.
The types of healthcare distribution available are pharmaceutical product distribution services, medical device distribution services and biopharmaceutical product distribution services. Pharmaceutical product distribution services are further classified as over-the-counter drugs/vitamins, brand-name/innovator drugs, and generic drugs. Biopharmaceutical product distribution services are further classified as monoclonal antibodies, vaccines, recombinant proteins, blood and blood products, amongst others.
Healthcare distribution can have different end-uses like in retail pharmacies and hospital pharmacies, amongst others.
The leading players in this market are McKesson Corporation [MCK (NYSE)], Cardinal Health [CAH (NYSE)], AmerisourceBergen Corporation [ABC (NYSE)], Owens & Minor, Inc. [OMI (NYSE)], Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, Dakota Drug, Inc., Others.
The global healthcare distribution market attained a value of USD 935.46 billion in 2023, driven by the growing significance of generics and the expanding biosimilars and medical equipment industries due to the advancement in technology. Aided by increasing prevalence of chronic diseases, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 7.1%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the type, the healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services and biopharmaceutical product distribution services. Pharmaceutical product distribution services are further classified as over-the-counter drugs/vitamins, brand-name/innovator drugs and generic drugs. Biopharmaceutical product distribution services are further classified as monoclonal antibodies, vaccines, recombinant proteins, blood and blood products, amongst others. Healthcare distribution can have different end-uses like in retail pharmacies and hospital pharmacies, amongst others. The key players in the above industry include McKesson Corporation [MCK (NYSE)], Cardinal Health [CAH (NYSE)], AmerisourceBergen Corporation [ABC (NYSE)], Owens & Minor, Inc. [OMI (NYSE)], Morris & Dickson Co. L.L.C., Priority Healthcare Distribution, Inc., FFF Enterprises, Inc., Attain Med, Dakota Drug, Inc., Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.